News

2017 Rocky Mountain Life Science Investor and Partnering Conference welcomes 40 investors and strategic partners

Presenters include 29 public and private companies from Rocky Mountain states

DENVER – Colorado BioScience Association (CBSA) today announced the full list of investors and strategic partners set to hear company pitches at the 2017 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) from 29 life science companies representing innovation from four Rocky Mountain states.

The 2017 conference, to be held in Beaver Creek, Colo. on October 2 and 3, brings high-profile angel investors, venture capitalists, and representatives from large life science corporations to meet leaders from emerging and established life science companies from Arizona, Colorado, Montana, New Mexico and Utah. A total of 40 investor representatives will attend.

April Giles, President and CEO of Colorado BioScience Association (CBSA), said:

“The Rocky Mountain Life Science Investor and Partnering Conference brings well-known investors from across the country to meet with our region’s most innovative companies. We design this dynamic conference to highlight the breakthroughs coming out of our region. It gives investors and companies the opportunity to get to know each other through formal presentations and informal networking sessions in a relaxed mountain environment.”

The participating investment firms include:

Angel Investors

Aphelion Capital

Artiman

AngelMD

Boomtown Accelerator

Boulder Ventures

Charter Life Sciences

Colorado Impact Fund

GSK

Green Park & Golf Ventures

HealthQuest Capital

High Country Venture

Hyalescent Ventures

Kensington Ventures

KMG Capital Partners

Lightstone Ventures

McGregor & Associates

Medtronic

Meridian Street Capital

Merck

NanoDimension

New Enterprise Associates

Oxford Finance

Providence Ventures

Samsung Ventures

Sanderling Ventures

Triple Tree

UCHealth CARE Innovation Center

Volcano Capital

White Hat Health Ventures

Following a breakfast keynote presentation on bioscience and impact investing by Stephanie Gripne,

Ph.D., Founder and Executive Director of the Impact Finance Center, investors and partners will hear pitches from the 29 companies chosen to present. For the first time, the presenting companies include three publicly traded firms, ARCA Biopharma, miRagen and ProLung.

Steve Lindseth, Senior Advisor at Triple Tree Capital Partners, will discuss the investment landscape for healthcare innovation from the investor perspective during the lunch keynote.

The 2017 Rocky Mountain Life Science Investor & Partnering Conference, led by the Colorado BioScience Association in collaboration with associations in Arizona, Montana, New Mexico and Utah, will kick off with a cocktail networking reception at Beaver Creek’s Park Hyatt Hotel on October 2, followed by a full day of company pitch presentations on October 3. A full agenda can be found online.

Event hashtag: #RockyBioInvest

About the Colorado BioScience AssociationThe Colorado BioScience Association (CBSA) is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 350 members, CBSA actively works to promote the growth of the industry by working for a better business environment, grow the state's bioscience workforce, advocate for policies that support a strong bioscience industry in the state, and speak with a single voice on behalf of the industry. For more information, visit http://www.cobioscience.com.

Media Contacts:

Sheliah Reynolds

Primavera Group for Colorado BioScience Association

(720) 289-4739

sheliah@theprimaveragroup.com



Go Back